Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow A corrigendum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hecht, S. S.
Right arrow Articles by Trushin, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hecht, S. S.
Right arrow Articles by Trushin, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 1851-1854, Copyright © 1997 by Oxford University Press

ARTICLES

Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone

SS Hecht, TE Spratt and N Trushin
University of Minnesota Cancer Center, Minneapolis 55455, USA.

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) is an important metabolite of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK). Using the chiral derivatizing agent, (R)- (+)-alpha-methylbenzyl isocyanate [(R)-(+)-MBIC], previous work has shown that the enantiomeric ratio of metabolically formed NNAL and its glucuronide derivative may be species dependent. However, the absolute configuration of such NNAL has not been previously reported. Synthetically prepared racemic NNAL was converted to diastereomeric esters by reaction with (R)-(+)- and (S)-(-)-alpha-methoxy-alpha- (trifluoromethyl)phenylacetic acid (MTPA) chloride (Mosher's reagent) and the products were characterized by 1H-NMR. Based on chemical shift data, the absolute configuration of NNAL in each diastereomeric ester was assigned. Hydrolysis of (R)-NNAL-(R)-MTPA gave (R)-NNAL. This was converted to the corresponding carbamate by reaction with (R)-(+)-alpha- MBIC and the absolute configurations of the diastereomeric carbamates formed by reaction of (R)- and (S)-NNAL with (R)-(+)-MBIC were thereby assigned. Conversion of metabolically produced NNAL to the same carbamates allowed us to assign the NNAL formed from NNK by rat liver microsomes as (R)-NNAL. The major and minor NNAL-glucuronide diastereomers found in the urine of patas monkeys and humans exposed to NNK were similarly assigned; they were formed from (R)-NNAL and (S)- NNAL, respectively.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
U. Breyer-Pfaff, H.-J. Martin, M. Ernst, and E. Maser
ENANTIOSELECTIVITY OF CARBONYL REDUCTION OF 4-METHYLNITROSAMINO-1-(3-PYRIDYL)-1-BUTANONE BY TISSUE FRACTIONS FROM HUMAN AND RAT AND BY ENZYMES ISOLATED FROM HUMAN LIVER
Drug Metab. Dispos., September 1, 2004; 32(9): 915 - 922.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. L. Zimmerman, Z. Wu, P. Upadhyaya, and S. S. Hecht
Stereoselective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
Carcinogenesis, July 1, 2004; 25(7): 1237 - 1242.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Z. Wu, P. Upadhyaya, S. G. Carmella, S. S. Hecht, and C. L. Zimmerman
Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereoselective metabolism and tissue distribution
Carcinogenesis, January 1, 2002; 23(1): 171 - 179.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. Prokopczyk, N. Trushin, J. Leszczynska, S. E. Waggoner, and K. El-Bayoumy
Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via {{alpha}}-hydroxylation and carbonyl reduction pathways
Carcinogenesis, January 1, 2001; 22(1): 107 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
Q. Ren, S. E. Murphy, Z. Zheng, and P. Lazarus
O-Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1- (3-Pyridyl)-1-Butanol (nnal) by Human Udp-Glucuronosyltransferases 2b7 and 1a9
Drug Metab. Dispos., November 1, 2000; 28(11): 1352 - 1360.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
P. Upadhyaya, S. G. Carmella, F.P. Guengerich, and S. S. Hecht
Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues
Carcinogenesis, June 1, 2000; 21(6): 1233 - 1238.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. S. Hecht, S. G. Carmella, and S. E. Murphy
Effects of Watercress Consumption on Urinary Metabolites of Nicotine in Smokers
Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 907 - 913.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
Q. Ren, S. E. Murphy, A. J. Dannenberg, J. Y. Park, T. R. Tephly, and P. Lazarus
Glucuronidation of the Lung Carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by Rat UDP-Glucuronosyltransferase 2B1
Drug Metab. Dispos., September 1, 1999; 27(9): 1010 - 1016.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
P. Upadhyaya, P. M.J. Kenney, J. B. Hochalter, M. Wang, and S. S. Hecht
Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse
Carcinogenesis, August 1, 1999; 20(8): 1577 - 1582.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. G. Carmella, M. Ye, P. Upadhyaya, and S. S. Hecht
Stereochemistry of Metabolites of a Tobacco-specific Lung Carcinogen in Smokers' Urine
Cancer Res., August 1, 1999; 59(15): 3602 - 3605.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.